Capital Advisor Network’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Capital Advisor Network's REGN Position: Q3 2026 in Review
Capital Advisor Network increased its Regeneron Pharmaceuticals (REGN) stake by 6.3% in Q3 2026, buying an estimated $756 and bringing the position to 17 shares worth $12.9K. The position accounts for 0.02% of the portfolio, ranked #116.
Capital Advisor Network first reported a position in REGN in Q1 2026 and has held it in 3 quarters since. The position peaked at $29.4K in Q1 2026. 1,432 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Capital Advisor Network held 17 shares of Regeneron Pharmaceuticals worth $12.9K as of Q3 2026.
- Capital Advisor Network bought 1 Regeneron Pharmaceuticals share in Q3 2026, an estimated $756.
- Regeneron Pharmaceuticals made up 0.02% of Capital Advisor Network's portfolio in Q3 2026, its #116 holding.
- Capital Advisor Network first reported a position in Regeneron Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- Capital Advisor Network's Regeneron Pharmaceuticals position peaked at $29.4K in Q1 2026.
- 1,432 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Capital Advisor Network's 13F filing for Q3 2026, filed 13 Nov 2026.